Loading...
XSTO
MCAP
Market cap853mUSD
Dec 05, Last price  
534.00SEK
1D
-1.11%
1Q
-11.88%
Jan 2017
1,438.90%
IPO
4,007.69%
Name

MedCap AB (publ)

Chart & Performance

D1W1MN
XSTO:MCAP chart
P/E
38.63
P/S
4.43
EPS
13.82
Div Yield, %
Shrs. gr., 5y
1.96%
Rev. gr., 5y
19.00%
Revenues
1.81b
+13.82%
188,857,000187,055,000258,787,000315,887,000336,510,000349,041,000826,086,000852,754,000816,918,000851,668,000411,200,000709,000,000757,100,000817,400,000916,300,0001,111,400,0001,587,400,0001,806,800,000
Net income
207m
+20.44%
-7,727,000114,0005,797,00013,511,00010,705,00017,112,00022,608,0008,524,00019,452,00073,0002,100,000600,00053,700,00060,900,00096,500,000117,600,000172,200,000207,400,000
CFO
360m
+57.89%
2,146,0003,373,00017,317,00030,637,00028,749,00038,550,000865,0002,258,000-14,917,00081,456,00027,300,00090,600,00071,400,000115,600,000116,300,00085,500,000228,000,000360,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.
IPO date
Jul 04, 2006
Employees
463
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑042016‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT